STMS.co.il Competitors

Weber Shandwick is the earned-first global communications agency. Led by world-class strategic and creative thinkers and activators, Weber Shandwick has won some of the most prestigious awards in the industry, including being named #1 in the Public Relations and Brand Strategies category on Fast Company’s 2024 + 2025 Most Innovative Companies list, one of Fast Company’s Best Workplace for Innovators in 2023, PRWeek’s 2024 Global Agency of the Year, ranked #1 on PRovoke’s Global Creative Index in 2024 and honored on Ad Age’sA-List in 2025, 2024 & 2020 and Best Places to Work in 2019, in addition to being awarded Campaign Global’s PR Agency of the Year in 2023. Weber Shandwick was the most awarded PR agency at the 2023 and 2024 Cannes Lions International Festival of Creativity for the past three years, including earning the PR industry’s first-ever idea-led Cannes Grand Prix in the Brand Experience & Activation category and cumulatively earning more than250Cannes Lions. Weber Shandwick has also been named PR Agency of the Year by Campaign USin 2021, honored asPRovoke’sGlobal Agency of the Decade in 2020 and ranked #1 on PRovoke’s Global Creative Index in 2021 and 2022. Additionally, the firm was named PRWeek’sGlobal Agency of the Year in 2015, 2016, 2017 and 2018 and was awarded PRWeek’s Purpose Agency of the Year in 2020 and 2021. Weber Shandwick also receivedHonorable Mention on the Gartner Magic Quadrant for Global Marketing Agencies in 2021, as the only PR agency featured. Weber Shandwick is part of Omnicom Public Relations and Omnicom (NYSE: OMC). For more information, visithttps://www.webershandwick.com/. Social Media Community Guidelines: http://bit.ly/wssocialterms

Eldan Transportation, part of the Eldan Group, is Israel’s leading car rental company, with a fleet of 35,000 vehicles. The Eldan Group has earned a reputation for commitment to progress, innovation and a wide array of products, without compromising on quality and consistently aspiring to excellence. In June 2010, as part of restructuring, the Group was split into two distinct spheres of activity: the vehicle domain, which manages vehicle leasing, rentals and sales; and the real estate and hotel domain which coordinates all investment, real estate development and hoteliering activities. The Eldan headquarters, serving both spheres of activity, manages the other investment activities of the Group. Car Rental in Israel - The company operates a fleet of 15,000 rental vehicles through 22 rental branches throughout Israel, from Kiryat Shmona to Eilat. In addition to meeting the needs of tourists, Eldan offers car rental services in Israel, to both the commercial and the private sectors. The company also has two overseas branches – in Paris and in London, where customers can book rental cars for their trips to Israel. Eldan provides solutions for a very wide variety of customers, through its fleet of 20,000 leasing vehicles, combining attractive rates with the highest standard of quality service. Eldan operates 33 branches in Israeli companies, providing their employees with personal and professional service.

Privately-held InSight Biopharmaceuticals Ltd. has been a player in the biotechnology field since 1995. It is active in the development of biosimilars and innovative biologics and diagnostics. Over the past 15 years InSight has established strategic alliances and developed technologies for manufacturing a wide spectrum of recombinant protein-based generic biopharmaceuticals (biogenerics). These technologies were designed to yield high quality products while being highly efficient, cost-effective, and competitive, thus enabling manufacturing for a significant stake of target markets in relatively small GMP local plants. Having successfully commercialized these technologies, InSight is continuously upgrading its position as a biogenerics developer, both for developing countries and for the highly regulated (ICH) markets. InSight is extensively involved in the development of front-edge biopharmaceuticals and has an impressive track record of scientific discoveries. Using its drug discovery platforms, InSight's scientists were the first to clone the gene coding for human Heparanase (hpa), a key enzyme in cancer and inflammatory processes. Based on its discoveries, inventions and strong intellectual property, InSight is focused on the development of novel anti-cancer drugs and cancer diagnostics.